transfluthrin: Clinical Trials

9 trials of transfluthrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 withdrawn. 8 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 5, Withdrawn 3
Phase 31Completed 1

Follow transfluthrin: new trials by email Literature Review of transfluthrin trials Research Report on transfluthrin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities
Mesh - spatial repellent impregnated with transfluthrin (2500mg), Information and Education Campaigns (IEC), test and treat malaria cases - Malaria, Childhood ALL
Phase 3CompletedThe Mentor Initiative24002023-06-052024-04-23
Spatial Repellents for Aedes-borne Virus Control in Sri Lanka
Transfluthrin, Placebo - Arbovirus Infections
Not applicableCompletedUniversity of Notre Dame69492023-03-022025-09-15
Spatial Repellents for Vector Control
Transfluthrin, Placebo - Malaria
Not applicableCompletedUniversity of Notre Dame19112021-07-082024-04-02
Spatial Repellents for the Prevention of Malaria in Kenya
Transfluthrin, Placebo - Malaria
Not applicableCompletedUniversity of Notre Dame59842021-03-022024-04-15
Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya
Spatial Repellent product with active ingredient, Active ingredient, Spatial Repellent product without active ingredient (SHIELD) - Malaria
Not applicableWithdrawnUniversity of Notre Dame2016-06-012016-10-06
Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)
Spatial Repellent product with active ingredient (SHIELD), Active Ingredient, Spatial Repellent product without active ingredient (SHIELD) - Malaria
Not applicableWithdrawnUniversity of Notre Dame2016-03-012016-10-06
Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania
Spatial Repellent product with active ingredient, Active ingredient, Spatial Repellent product without active ingredient (SHIELD) - Malaria
Not applicableWithdrawnUniversity of Notre Dame2016-02-012016-10-06
Spatial Repellents for Arbovirus Control
transfluthrin, placebo - Arbovirus Infections
Not applicableCompletedUniversity of Notre Dame182402015-06-012021-03-05
Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia
Spatial Repellent product with active ingredient (SHIELD), Active ingredient, Spatial Repellent product without active ingredient (SHIELD) - Malaria
Not applicableCompletedUniversity of Notre Dame15192015-05-012018-05-03

Conditions studied

Malaria (7)  ·  Vector Borne Diseases (4)  ·  Arbovirus Infections (2)  ·  Chikungunya Fever (2)  ·  Dengue (2)  ·  Zika Virus Infection (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

University of Notre Dame (8)  ·  The Mentor Initiative (1)

Countries

Kenya (2)  ·  Indonesia (1)  ·  Mali (1)  ·  Peru (1)  ·  Sri Lanka (1)  ·  Tanzania (1)  ·  United Kingdom (1)  ·  Zambia (1)

Top investigators

John P Grieco, Ph.D. (3)  ·  Neil F Lobo, PhD (2)  ·  Neil Lobo, PhD (2)  ·  Nicole Achee, PhD (2)  ·  Nicole L Achee, PhD (2)  ·  Eric Ochomo, Ph.D. (1)  ·  Korelege Hasitha Aravinda Tissera, M.D. (1)  ·  Richard Allan (1)  ·  Suzanne Van Hulle, M.H.S (1)

Results publications

PMID 35382856, PMID 35382858, PMID 39709979, PMID 41520670